Richard M. Toselli's most recent trade in InVivo Therapeutics Holdings Corp was a trade of 61,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 17, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InVivo Therapeutics Holdin... | Richard M. Toselli | Director, CEO and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 61,000 | 61,000 | - | - | Stock Option (right to buy) | |
| InVivo Therapeutics Holdin... | Richard M. Toselli | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.56 per share. | 21 Dec 2021 | 16 | 6,201 (1%) | 0% | 0.6 | 9 | Common Stock |
| InVivo Therapeutics Holdin... | Richard M. Toselli | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. | 21 Jun 2021 | 21 | 6,217 (1%) | 0% | 0.8 | 16 | Common Stock |
| InVivo Therapeutics Holdin... | Richard M. Toselli | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| InVivo Therapeutics Holdin... | Richard M. Toselli | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 21 Dec 2020 | 16 | 6,238 (1%) | 0% | 0.6 | 10 | Common Stock |